NPR interviewed Dr. Richard Schlegel about his research with conditionally reprogrammed cells.
USA Today profiled Dr. Daniel Lucey highlighting his experience in the Ebola hot zone.
Dr. Michael Ullman joined a panel of experts on The Diane Rehm Show to talk about the brain and learning multiple languages.
CBS News Radio interviewed Dr. Ranit Mishori about why mortality among pregnant women is increasing.
Two of the top 10 most read news articles in the ASCO Post featured studies presented by Georgetown Lombardi researchers, including Dr. Sandra Swain and Dr. Bruce Cheson.
Dr. James Giordano weighed in on the issue of neurosecurity with io9.
Dr. John VanMeter's study on common factors for teens at risk for alcohol abuse reported by Psych News Central.
Medscape covered a presentation in which Dr. Jacqueline Jonklaas discussed controversial hypothyroidism treatment guidelines.
AlzForum and Medscape reported on Dr. Scott Turner's preliminary results from the resveratrol study for Alzheimer's.
Medscape talked to Dr. Kevin Donovan about the many ethical decisions facing physicians.
International Business Journal quoted Dr. Ranit Mishori regarding the lack of evidence that cleansing diets are beneficial.
WTOP conducted a live interview with Dr. Dan Lucey about Ebola (clip not yet available).
Oncology Times reports on a meeting held by the Ruesch Center at Georgetown in November about the need for research funding.
Corey Carson, a senior resident, wrote an article about prolotherapy that was published in The Washington Post.
Dr. Louis Weiner commented on the FDA approval of a "biosimilar" drug in HemOnc Today.
US News & World Report interviewed Dean Ray Mitchell about students transferring in medical school.
The Ruesch Center for the Cure of GI Cancers annual symposium in December received robust coverage by Medscape:
In a video blog, Dr. John Marshall drills down on immunotherapy for GI cancers.
Dr. Marshall also discussed in an article the use of immunotherapy in GI cancers.
Drs. Marshall, He, Pishvaian and Smaglo reviewed GI treatment advances made in 2014.
Drs. Marshall and Pishvaian discuss molecular profiling and cancer costs.
Special note:
In December, GUMC hosted 16 journalists from the National Press Foundation for a half-day tour and lectures featuring Drs. Michael Atkins, Richard Schlegel, Anna Riegel, Sherrie Wallington and Anton Wellstein. Topics during the visit included conditionally reprogrammed cells (CRCs), CRCs applied to breast cancer research, HPV vaccine development and HPV vaccination challenges.
